Skip to main content

Closed

AUTL: Autolus Therapeutics plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-285.9%

ROIC-56.7%

Financially safe

Stretched

Debt / equity0.73×

Interest coverage-6.0×

Current ratio5.80×

Autolus Therapeutics plc

AUTLNASDAQ Global Select·USD·Closed

Autolus Therapeutics plc

AUTLNASDAQ·USD·Closed

$1.49

−2.61%

$1.49

−$0.04 (2.61%)

52W Range

23thpctl

Volume

0.54×avg

Mkt Cap

396.55MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

23thpctl

Volume

0.54×avg

Market Cap

396.55MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings